The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays

The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays

Patients on P2Y12 inhibitors may still develop thrombosis or bleeding complications. Tailored antiplatelet therapy, based on platelet reactivity testing, might reduce these complications. Several tests have been used, but failed to show a benefit of tailored antiplatelet therapy. This could be due t...

Full description

Bibliographic Details
Main Authors: Tesse C. Leunissen, Peter Paul Wisman, Thijs C. van Holten, Philip G. de Groot, Suzanne J. Korporaal, Arnold C. Koekman, Frans L. Moll, Martin Teraa, Marianne C. Verhaar, Gert Jan de Borst, Rolf T. Urbanus, Mark Roest
Format: Article
Language:English
Published: Taylor & Francis Group 2017-08-01
Series:Platelets
Subjects:
platelet aggregation
platelet aggregation inhibitor
platelet function test
platelet membrane glycoprotein iib
p-selectin
Online Access:http://dx.doi.org/10.1080/09537104.2016.1246713

Internet

http://dx.doi.org/10.1080/09537104.2016.1246713

Similar Items